These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12166456)

  • 1. Rituximab for treatment of intermediate and aggressive B-cell non-Hodgkin's lymphomas.
    TEC Bull (Online); 2002 Apr; 19(1):19-21. PubMed ID: 12166456
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.
    King KM; Younes A
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):177-86. PubMed ID: 12113023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: new indication. In aggressive non Hodgkin lymphoma: benefits must be confirmed.
    Prescrire Int; 2003 Aug; 12(66):125-6. PubMed ID: 12906019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of rituximab and its clinical use: thought for the best use?
    Cartron G; Blasco H; Paintaud G; Watier H; Le Guellec C
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):43-52. PubMed ID: 17287129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy for low-grade lymphomas: has the time come?
    Cartron G; Solal-Céligny P
    Curr Opin Oncol; 2007 Sep; 19(5):425-32. PubMed ID: 17762565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell non-Hodgkin's lymphoma: rituximab safety experience.
    Mohrbacher A
    Arthritis Res Ther; 2005; 7 Suppl 3(Suppl 3):S19-25. PubMed ID: 15960818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label uses of monoclonal antibodies for treatment of B-cell lymphoid or myeloid malignancies.
    Tecnologica MAP Suppl; 2001 Jul; ():14-7. PubMed ID: 11718149
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma.
    Kosits C; Callaghan M
    Oncol Nurs Forum; 2000; 27(1):51-9. PubMed ID: 10660923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special report: maintenance therapy in advanced non-small-cell lung cancer.
    Technol Eval Cent Assess Program Exec Summ; 2011 Jul; 26(4):1-3. PubMed ID: 22022747
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma.
    Traullé C; Coiffier BB
    Future Oncol; 2005 Jun; 1(3):297-306. PubMed ID: 16556002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma.
    Eur J Cancer Care (Engl); 2003 Dec; 12(4):306-7. PubMed ID: 14982308
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
    Akhtar S; Maghfoor I
    J Clin Oncol; 2005 Sep; 23(25):6261; author reply 6262. PubMed ID: 16135496
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab (Rituxan/MabThera): the first decade (1993-2003).
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):767-79. PubMed ID: 14686699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura.
    Milani C; Castillo J
    Curr Opin Mol Ther; 2009 Apr; 11(2):200-7. PubMed ID: 19330725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rituximab in the treatment of indolent non-Hodgkin's lymphoma].
    Aurer I; Mitrović Z; Radman I; Kovacević-Metelko J; Nemet D; Serventi-Seiwerth R; Stern-Padovan R; Jakic-Razumović J; Nola M; Zupancić-Salek S; Sertić D; Labar B
    Lijec Vjesn; 2004; 126(11-12):307-11. PubMed ID: 16082888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inefficacy of rituximab in a case of low grade non-Hodgkin's lymphoma with cryoglobulinemia.
    Baronciani D; Angelucci E; Gaziev J; Visani G
    Haematologica; 2002 Jul; 87(7):ELT33. PubMed ID: 12091148
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
    Meinhardt A; Burkhardt B; Zimmermann M; Borkhardt A; Kontny U; Klingebiel T; Berthold F; Janka-Schaub G; Klein C; Kabickova E; Klapper W; Attarbaschi A; Schrappe M; Reiter A;
    J Clin Oncol; 2010 Jul; 28(19):3115-21. PubMed ID: 20516455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rituximab].
    Okamoto R; Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1085-93. PubMed ID: 12938262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.